Two GCI researchers receive funding to spearhead pan-Canadian research projects on rare and aggressive cancers
By Daniel Caron, Senior Communications Advisor, Rosalind and Morris Goodman Cancer Institute
April 11, 2024
George Zogopoulos, MD, PhD., Morag Park, PhD.
Two projects led by Morag Park, PhD, and George Zogopoulos, MD, PhD, from the Rosalind and Morris Goodman Cancer Institute (GCI) received funding for research on aggressive and rare cancers through a $3,531,000 investment by the MOHCCN Pan-Canadian Projects program and partners.
